Fig. 9

A Schematic diagram of in vivo anti-infective efficiency of different treatment on the diabetic mice wound infected by MRSA. B Representative pictures of MRSA-infected full-thickness wounds on C57BL/6 mice with different treatments on days 0, 1, 3, 6, 9, and 12. C Representative histopathological observation of H&E staining, MTS, and Giemsa staining of dermal wound paraffin section collected on day 12. D Immunohistochemical staining of CD31 and CD86 of the dermal wound paraffin section collected on day 12. E Immunofluorescence staining of CK14 (red), IL-6 (green), TNF-α (green) and cell nucleus (blue) of dermal wound paraffin section collected on day 12